Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-02 @ 9:58 PM
Study NCT ID:
NCT05724069
Status:
COMPLETED
Last Update Posted:
2025-08-03
First Post:
2023-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).
Sponsor:
Alfasigma S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VE-CIP2001/2021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None